Abstract
Background:
Stress urinary incontinence (SUI) is the most common type of urinary incontinence, affecting patients’ quality of life and sexual function. Lots of Clinical trials suggested that acupuncture is beneficial for SUI and various acupuncture methods have been widely used in clinic. However, the comparative efficacy and safety of these acupuncture methods remains unclear. Clinicians are confused to select the optimal way to treat SUI. This review aims to gather solid evidence in order to provide reliable reference in establishing guidelines for acupuncture treatment of SUI.
Methods:
Relevant databases including MEDLINE, Cochrane Library, EMBASE, Chinese National Knowledge Infrastructure, Chinese Biomedical Literature Database, Wanfang Database, the Chongqing VIP Chinese Science and Technology Periodical Database will be retrieved from their inception to April 2020. The quality of the included studies will be evaluated by the risk of bias tool and the evidence will be evaluated by Grading of Recommendations Assessment, Development and Evaluation System. Network meta-analysis will be conducted by using software R3.5.1. The primary outcome is the number of patients with self-reported continence and number of patients with self-reported improvement in SUI.
Results:
The results of this network meta-analysis will be submitted to a peer-reviewed journal for publication.
Conclusion:
the results may be useful for patients, clinicians, and guideline-makers to choose the optimal acupuncture method for SUI treatment.
Keywords: acupuncture, network meta-analysis, stress urinary incontinence, systematic review
1. Introduction
Stress urinary incontinence (SUI), the most common type of urinary incontinence, is defined as the involuntary loss of urine through physical exertion or effort, coughing or sneezing.[1] Prevalence of this disease is different in various parts of the world. A study conducted in USA reported that an estimated 49.6% of adult women are affected by SUI.[2] In China, the prevalence is14% in adult women.[3] SUI has a social, psychological, physical and financial impact on life. Over 80% of women without accept any treatment, and less than 1% undergo surgical management.[4] Because of the fear of leakage, patients’ quality of life and sexual function are often substantially impaired.[5] SUI can severely impact the ability to carry out daily activities, resulting in embarrassment, insomnia and social isolation.[6] Patients with SUI may be less likely to take part in physical activity, which in turn has a harmful impact on overall health because inactivity is a risk factor for many diseases.[7] Furthermore, SUI can cause a considerable economic burden for patients and healthcare providers.[8]
Treatment methods for SUI includes behavioral therapy, medications, physiotherapy, devices, and surgery.[9–12] Duloxetine is the recommended drug for the treatment of SUI, but it is poorly tolerated due to adverse effects or lack of efficacy. This result in high discontinuation rates.[13] Pelvic floor muscle training (PFMT) is one of the conservative therapies for SUI, it is more effective than no treatment, placebo drug or inactive control treatments for women with SUI.[14] However, Pelvic floor muscle training needs long-term adherence and its value remains uncertain for post-prostatectomy incontinence in men.[15] If conservative treatment has not improved patients’ symptoms, surgery is usually suggested as a second-line option.[16] But it has risks (such as urinary retention, impair the bladder or urethra and severe infection) that some people may find unacceptable.
Therefore, there is an urgent need for effective, lower cost, non-invasive treatment, especially for people living in low-income regions. As a minimally invasive treatment, acupuncture is reported to be effective in treating SUI.[17–19] Although it has not yet known how acupuncture produces its effects (e.g., whether on blood, muscles, nerves, or energy), it is possible that it could desensitize the bladder through inhibition of capsaicin-sensitive C-fiber activation. In recent years, various acupuncture methods has been used in treating SUI,[18–21] most of the trials only compare acupuncture methods with medicine or sham acupuncture methods and there are hardly any studies directly comparing difference acupuncture methods. Furthermore, whether a combination of multiple acupuncture methods or acupuncture methods plus other therapy is superior to single acupuncture is still unclear. Therefore, determining the best acupuncture methods for treating SUI is intractable.
This protocol will evaluate and rank the different acupuncture treatments by using the network meta-analysis (NMA) to analyze the direct and indirect randomized data,[15,22] and it will provide evidence to guide the best practice in acupuncture for SUI.
2. Methods
This protocol has been registered on the international prospective register of systematic review (PROSPERO), and it was drafted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols (PRISMA-P).[23] The final results will be reported according to the recommendation from The Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses.[24]
2.1. Criteria for considering studies for this review
2.1.1. Types of studies
We will include randomized controlled trials (RCTs) reporting in English or Chinese without any regional restrictions. The first period of randomized cross-over trials will be also included. We will exclude Non-RCTs reviews, animal experimental studies, case report, expert experience, conference article and duplicated publications.
2.1.2. Types of participants
Participants diagnosed with SUI will be included, regardless of age, race, duration of disease, weight, mode of delivery, or education.
2.1.3. Types of interventions
We will define acupuncture as acupoint-based therapies[25] (e.g., moxibustion, catgut embedding, electro-acupuncture, transcutaneous electrical acupoint stimulation, auricular acupuncture, scalp acupuncture, warm needling, manual acupuncture, acupoint injection, medium-frequency electric stimulation, and so on), regardless of needling techniques and stimulation method. We will rule out interventions without stimulating the acupoint.
2.1.4. Types of control groups
Treatments in the comparison groups can be sham-acupuncture, placebo, pharmacotherapy or rehabilitation exercise therapy. Studies compared different type of acupuncture methods will be included
2.1.5. Types of outcome measures
2.1.5.1. Primary outcomes
-
(1)
Cure: number of patients with self-reported continence.
-
(2)
Improvement: number of patients with self-reported improvement in SUI (cured or improved).
2.1.5.2. Secondary outcomes
The secondary outcomes include the following items:
-
1.
Incontinence-specific quality-of-life (QoL) measures defined by authors or by any validated measurement scales such as International Consultation on Incontinence Questionnaire
-
2.
QoL measures of general health status, for example, SF-36.
-
3.
Quantification of symptoms (e.g., number of incontinence episodes, number of micturitions, pad tests).
-
4.
Socioeconomic measures (e.g., costs of interventions, cost effectiveness of interventions in terms of incremental cost-effectiveness ratios, costs per quality-adjusted life year or cost-benefit ratios).
-
5.
Adverse effects (e.g., skin or tissue damage, pain or discomfort, vascular, visceral or nerve injury, voiding dysfunction).
-
6.
Residual urine volume
-
7.
Pelvic floor muscle strength or ability to contract the pelvic floor muscles, or both.
2.2. Search methods for identification of studies
2.2.1. Electronic searches
We will search the following databases from their inception to April 2020: MEDLINE, Cochrane Library, EMBASE, Chinese National Knowledge Infrastructure (CNKI), Chinese Biomedical Literature Database (CBM), Wanfang Database, the Chongqing VIP Chinese Science and Technology Periodical Database (VIP). we will also search grey literature from World Health Organization Clinical Trials Registry, ClinicalTrials.gov and Chinese clinical registry. Reference lists of articles will be retrieved as additional studies.
The following search headings (MeSH) will be used: “stress urinary incontinence”, “urinary stress incontinence,” urinary stress,” urinary”, “acupuncture,” “electro acupuncture,” “auriculotherapy,” “acupoint,” “needle,” “acupoint catgut embedding,” “moxibustion,” “transcutaneous electrical acupoint stimulation,” acupoint injection,” “randomized controlled trial,” randomized controlled,” “randomized, controlled,” “clinical trial.” Chinese translations of these search terms will be used for the Chinese databases. The search strategy for MEDLINE is shown in Table 1.
Table 1.
Illustration of the search strategies applied to this review (Table 1 Search strategy in Medline (Ovid SP)).

2.3. Data collection and analysis
2.3.1. Selection of studies
Two reviewers will independently search articles from titles and abstracts. Full texts will be searched for further evaluation when necessary. Then, the reviewers will examine the full text articles according to the inclusion criteria. For each excluded study, reason (s) for exclusion will be given. In cases of conflicting opinions, a third reviewer will be consulted to resolve any disagreement. Details of the selection process will be presented in the PRISMA flow chart (Fig. 1).
Figure 1.

Illustration of the flow diagram of studies identified.
2.3.2. Data extraction and management
Two reviewers will independently extract parameters from applicable studies including identification information (publication year and first author), general information (country, study type, number of centers, sample size), participants (age, sex, weight, mode of delivery, original disease), interventions (type of acupuncture, frequency/session/duration), comparator (if there is any, details of the treatment including name, dosage, frequency and course), outcomes (data and time points for each measurement, safety).
2.3.3. Dealing with missing data
If the required data are ambiguous or not reported in the included articles, the corresponding authors of the studies will be contacted by telephone or email.
2.3.4. Assessment of quality in included studies
The quality of the studies will be assessed according to the Cochrane risk of bias assessment tool.[26] The main contents include: sequence generation, allocation concealment, blinding (or masks), incomplete data assessment, selective outcome reporting and other sources of bias. Then, the risk of bias for included studies will be classified as “low”, “unclear” and “high” risk of bias. The above content evaluation will be performed by 2 researchers, and any differences will be resolved through discussions or consultation with the third reviewer. The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system will be used to grading the quality of the evidence for main outcomes.[27] Evidence quality will be graded as “high”, “moderate”, “low” or “very low” according to the GRADE rating standards.
2.4. Statistical analysis
2.4.1. Pairwise meta-analysis
Traditional pairwise meta-analysis will be performed to compare treatments with direct evidence. Continuous outcomes will be calculated as standardized mean differences (SMDs) with 95% confidence interval (95% CI), and dichotomous outcomes will be calculated as OR with 95% CI. The heterogeneity of each pairwise comparison will be tested by I2 test. If I2 < 50%, fixed-effect model will be used, whereas a random-effect model will be used. And we will explore the reasons for the existence of heterogeneity from various aspects such as age, duration of disease and mode of delivery. If it is necessary, sensitivity analysis or meta-regression and subgroup analysis will be used to explore possible sources of heterogeneity. If 8 or more studies are involved in the meta-analysis, the publication bias will be evaluated using funnel plots. The funnel plot asymmetry will be evaluated by Egger test.
2.4.2. Network meta-analysis
R3.5.1 software (AT&T, USA) will be used to perform NMA to synthesize direct and indirect evidence with Bayesian method.[28] Reliability of the result of network meta-analysis largely depends on transitivity of the evidence network. However, it is difficult to determine transitivity by statistical analysis, so we will evaluate the transitivity from clinical and methodological variables that could act as effect modifiers across treatment comparisons.[29] Moreover, the node splitting method will be performed to estimate the consistency of direct and indirect evidence in each closed loop according to the resultant P-value.[30] Values of P > .05 indicate good consistency, otherwise, all inconsistencies will be reported (P < .05). The contribution of different designs to the final effect size estimated by the network meta-analysis will be evaluated by using net-heat plots.
The different acupuncture methods will be ranked by using P-score that measures the extent of certainty that a treatment is better than a control.[31] 100% of the P-score indicates a treatment to be the best, while 0% of a P-score indicates a treatment to be the worst.
3. Discussion
Despite the lack of robust evidence, acupuncture is widely used for SUI in clinical practice. Choosing the optimal acupuncture method is difficult for clinicians due to the lack of comparative effect research. In this review, we will evaluate the comparative efficacy and safety of various acupuncture methods and combination regimens for the treatment of SUI. Network meta-analysis will summarize direct and indirect evidence aiming to provide a ranking of the acupuncture treatment for SUI.[22,32] As less randomized trials directly evaluate the comparisons of different acupuncture methods, this study will provide the current best evidence by using network meta-analysis
This review will be the first to compare the efficacy and safety of various acupuncture therapies for SUI. But there are some limitations in this study. Frist, we will only include trials writing in Chinese or English. It could limit available data or result in language bias. Second, the quality of original trials will affect the quality of the pooled effects, so we will strictly control the quality of the included studies and the similarity of the basic characteristics of the study. Our review will offer credible evidence for the clinicians and encourage wider application of acupuncture for SUI.
Acknowledgments
The authors thank Guixing Xu for her helpful assistance.
Author contributions
Data curation: Jiao Yang and Ying Cheng.
Methodology and investigation: Jiao Chen and Qianhua Zheng.
Resources: Jiao Yang and Ling Zhao.
Software: Yaoguang Guo.
Writing – original draft: Jiao Yang and Yaoguang Guo.
Writing – review & editing: Fanrong Liang.
Footnotes
Abbreviations: CI = confidence interval, GRADE = Grading of Recommendations Assessment, Development and Evaluation System, NMA = network meta-analysis, PFMT = pelvic floor muscle training, RCT = randomized controlled trials, SMD = standardized mean differences, SUI = stress urinary incontinence, WMD = weighted mean difference.
How to cite this article: Yang J, Cheng Y, Zhao L, Chen J, Zheng Q, Guo Y, Liang F. Acupuncture and related therapies for stress urinary incontinence: a protocol for systematic review and network meta-analysis. Medicine. 2020;99:28(e21033).
JY and YC contributed equally to this work.
This work was funded by National Natural Science Foundation of China (No. 81590950, No.81590951) and Sichuan research center for collaborative development of traditional Chinese medicine and culture (NO. ZYYWH1812).
Provider financially supports this work, but does not involve all sections of this work, and does not have conflicts of interest related to this work.
This work did not require ethical approval. The results may be published in a peer-reviewed journal or disseminated in relevant conferences.
INPLASY registration number: INPLASY202050061
The authors have no conflicts of interest to disclose.
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
- [1].Bo K, Frawley HC, Haylen BT, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for the conservative and nonpharmacological management of female pelvic floor dysfunction. Int Urogynecol 2017;28:191–213. [DOI] [PubMed] [Google Scholar]
- [2].Reynolds WS, Dmochowski RR, Penson DF. Epidemiology of stress urinary incontinence in women. Curr Urol Rep 2011;12:370–6. [DOI] [PubMed] [Google Scholar]
- [3].Liu B, Wang L, Huang S-S, et al. Prevalence and risk factors of urinary incontinence among Chinese women in Shanghai. Int J Clin Exp Med 2014;7:686–96. [PMC free article] [PubMed] [Google Scholar]
- [4].Miller D. Office management of stress incontinence: current and future role. Clin Obstet Gynecol 2007;50:376–82. [DOI] [PubMed] [Google Scholar]
- [5].Oh SJ, Ku JH, Choo MS, et al. Health-related quality of life and sexual function in women with stress urinary incontinence and overactive bladder. Int J Urol 2008;15:62–7. [DOI] [PubMed] [Google Scholar]
- [6].Bartoli S, Aguzzi G, Tarricone R. Impact on quality of life of urinary incontinence and overactive bladder: a systematic literature review. Urology 2010;75:491–500. [DOI] [PubMed] [Google Scholar]
- [7].Bø K, Hilde G, Tennfjord MK, et al. Pelvic floor muscle function, pelvic floor dysfunction and diastasis recti abdominis: prospective cohort study. Neurourol Urodyn 2017;36:716–21. [DOI] [PubMed] [Google Scholar]
- [8].Abrams P, Andersson KE, Apostolidis A, et al. 6th International Consultation on Incontinence. Recommendations of the International Scientific Committee: evaluation and treatment of urinary incontinence, pelvic organ prolapse and faecal incontinence. Neurourol Urodyn 2018;37:2271–2. [DOI] [PubMed] [Google Scholar]
- [9].Thüroff JW, Abrams P, Andersson KE, et al. EAU guidelines on urinary incontinence. Eur Urol 2011;59:387–400. doi:10.1016/j.eururo.2010.11.021. [DOI] [PubMed] [Google Scholar]
- [10].Qaseem A, Dallas P, Forciea MA, et al. Nonsurgical management of urinary incontinence in women: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2014;161:429–40. [DOI] [PubMed] [Google Scholar]
- [11].Freites J, Stewart F, Omar MI, et al. Laparoscopic colposuspension for urinary incontinence in women. Cochrane Database Syst Rev 2019;12:CD002239.Published 2019 Dec 10. doi:10.1002/14651858.CD002239.pub4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [12].Lapitan MCM, Cody JD, Mashayekhi A. Open retropubic colposuspension for urinary incontinence in women. Cochrane Database Syst Rev 2017;7:CD002912.Published 2017 Jul 25. doi:10.1002/14651858.CD002912.pub7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [13].Patel-Gadhia R, Bhal K, Patil P. Retrospective audit on tolerability and efficacy of duloxetine for stress urinary incontinence. J Obstet Gynaecol 2011;31:258–9. [DOI] [PubMed] [Google Scholar]
- [14].Dumoulin C, Cacciari LP, Hay-Smith EJC. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database Syst Rev 2018;10:CD005654.Published 2018 Oct 4. doi:10.1002/14651858.CD005654.pub4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [15].Anderson CA, Omar MI, Campbell SE, et al. Conservative management for postprostatectomy urinary incontinence. Cochrane Database Syst Rev 2015;1:CD001843.Published 2015 Jan 20. doi:10.1002/14651858.CD001843.pub5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [16].Scottish Government. The Scottish independent review of the use, safety and eIicacy of transvaginal mesh implants in the treatment of stress urinary incontinence and pelvic organ prolapse in women. Edinburgh: the Scottish Government; 2015 October. Interim report. Available at: www.gov.scot/ Resource/0048/00486661.pdf. [Google Scholar]
- [17].Kim JH, Nam D, Park MK, et al. Randomized control trial of hand acupuncture for female stress urinary incontinence. Acupunct Electrother Res 2008;33:179–92. [DOI] [PubMed] [Google Scholar]
- [18].Jiao R, Liu Y, Liu B, et al. Risk factors related to acupuncture response in postmenopausal women with stress urinary incontinence: secondary analysis of a randomized controlled trial. Medicine (Baltimore) 2019;98:e15220.doi:10.1097/MD.0000000000015220. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [19].Wang W, Liu Y, Sun S, et al. Electroacupuncture for postmenopausal women with stress urinary incontinence: secondary analysis of a randomized controlled trial. World J Urol 2019;37:1421–7. [DOI] [PubMed] [Google Scholar]
- [20].Tang CL, Dai DC, Zhu WF, et al. Observation on therapeutic effect of dog-day acupuncture and moxibustion combined with pelvic floor muscle exercises for treatment of female stress urinary incontinence. Chin Acupunct Moxibustion 2009;29:879–83. [PubMed] [Google Scholar]
- [21].Wang S, Lv J, Feng X, et al. Efficacy of electrical pudendal nerve stimulation in treating female stress incontinence. Urology 2016;91:64–9. [DOI] [PubMed] [Google Scholar]
- [22].Caldwell DM, Ades A, Higgins J. Simultaneous comparison of multiple treatments: combining direct and indirect evidence. BMJ 2005;331:897–900. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [23].Shamseer L, Moher D, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation [published correction appears in BMJ. 2016 Jul 21;354:i4086]. BMJ 2015;350:g7647.Published 2015 Jan 2. doi:10.1136/bmj.g7647. [DOI] [PubMed] [Google Scholar]
- [24].Hutton B, Salanti G, Caldwell DM, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med 2015;162:777–84. [DOI] [PubMed] [Google Scholar]
- [25].Yujie LiB S, Liyun H, Xiaodong W, et al. The current situation of acupuncture definition in international organizations and legislation of some countries. Chin Acupunct Moxibustion 2017;37:1329–32. [DOI] [PubMed] [Google Scholar]
- [26].Higgins, JPT. Cochrane handbook for systematic reviews of interventions version 5.0. 2[M]// Cochrane handbook for systematic reviews of interventions. [Google Scholar]
- [27].Guyatt GH, Oxman AD, Schünemann HJ, et al. GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. J Clin Epidemiol 2011;64:380–2. [DOI] [PubMed] [Google Scholar]
- [28].Cipriani A, Higgins JP, Geddes JR, et al. Conceptual and technical challenges in network meta-analysis. Ann Intern Med 2013;159:130–7. doi:10.7326/0003-4819-159-2-201307160-00008. [DOI] [PubMed] [Google Scholar]
- [29].Song F, Loke YK, Walsh T, et al. Methodological problems in the use of indirect comparisons for evaluating healthcare interventions: survey of published systematic reviews. BMJ 2009;338:b1147.Published 2009 Apr 3. doi:10.1136/bmj.b1147. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [30].Dias S, Welton N, Caldwell D, et al. Checking consistency in mixed treatment comparison meta-analysis. Stat Med 2010;29:932–44. [DOI] [PubMed] [Google Scholar]
- [31].Rücker G, Schwarzer G. Ranking treatments in frequentist network meta-analysis works without resampling methods. BMC Med Res Methodol 2015;15:58.Published 2015 Jul 31. doi:10.1186/s12874-015-0060-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [32].Salanti G. Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool. Res Synth Methods 2012;3:80–97. [DOI] [PubMed] [Google Scholar]
